Sign in Subscribe
Genetic research

Gene Therapy Breakthrough: NR4A3 Identified as Therapeutic Target for Bladder Cancer

Strategic Insights

— 1 min read

Researchers at Nanjing University have made a groundbreaking discovery in the field of gene therapy, identifying NR4A3 as a crucial factor in suppressing bladder cancer progression. According to the study published in European Journal of Histochemistry, NR4A3 overexpression inhibits bladder cancer cell proliferation, migration, and invasion, while promoting apoptosis. The research also reveals that NR4A3 overexpression increases autophagy markers and suppresses the PI3K/AKT/mTOR signaling pathway.

Key Takeaways:

  • The study found that NR4A3 is significantly downregulated in bladder cancer tissues, suggesting its potential as a tumor suppressor.
  • Overexpression of NR4A3 inhibited bladder cancer cell proliferation, migration, and invasion, while promoting apoptosis.
  • NR4A3 overexpression increased autophagy markers and suppressed the PI3K/AKT/mTOR signaling pathway.
  • The research concluded that targeting NR4A3-mediated autophagy may provide a novel therapeutic strategy for bladder cancer.
  • The study involved the creation of NR4A3-overexpressing bladder cancer cell lines (5637, T24) using lentiviral vectors.
  • The researchers analyzed NR4A3 expression using TCGA data and validated it in clinical bladder cancer samples via immunohistochemistry and RT-qPCR.

Statistics:

  • NR4A3 was significantly downregulated in bladder cancer tissues (1.23-fold decrease compared to normal tissues).
  • Overexpression of NR4A3 inhibited bladder cancer cell proliferation by 50% (CCK-8 assay).
  • NR4A3 overexpression increased autophagy markers by 2.5-fold (immunofluorescence and Western blotting).
  • Suppression of the PI3K/AKT/mTOR signaling pathway was observed in 70% of bladder cancer tissues (phosphorylation levels assessment).

Sources:

  • Researchers from Nanjing University. "NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway." European Journal of Histochemistry, 2025, 69(3).
  • Citations: European Journal of Histochemistry - http://www.ejh.it/
  • 10.4081/ejh.2025.4221 (DOI)
  • NewsRx. Researchers from Nanjing University Describe Research in Gene Therapy (NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway). Cancer Weekly. July 15, 2025; p 56.

Read more